Paxlovid
Paxlovid is a pharmaceutical drug with 12 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
5
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Randomised Evaluation of COVID-19 Therapy
RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19
AGILE (Early Phase Platform Trial for COVID-19)
A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants
Clinical Trials (12)
Randomised Evaluation of COVID-19 Therapy
RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19
AGILE (Early Phase Platform Trial for COVID-19)
A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants
Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings
The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19
A Registry Study of Patients Hospitalized With Confirmed COVID-19
UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients
Efficacy and Safety of JT001 (VV116) Compared With Paxlovid
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
Paxlovid in the Treatment of COVID-19 Patients With Uremia
All 12 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 12